In this issue:
DECEMBER 2022 Volume 18 Number 12
02 G uest editorial Arthur E. Palamara, MD, on Envision, private equity and patient care
18 J VS-VL Journal dedicated to venous disease set to go online-only
12 C omment & Analysis Bhagwan Satiani, MD, on learning culture, leaders and Melinda French Gates
23 VenoValve New firstin-human data emerge demonstrating benefits of prosthetic device
THE OFFICIAL NEWSPAPER OF THE
www.vascularspecialistonline.com
SUMMIT Women in vascular: Annual meeting dedicated to tackling key issues related to women’s vascular health and female workforce seeks to ‘enable and empower’ By Bryan Kay, Urmila Kerslake and Aaron Kudhail
Read the full story on page 4
Linda Harris
VASCULAR COMMUNITY STARTS PROCESS OF WRESTLING WITH FINDINGS FROM BEST-CLI One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BESTCLI randomized controlled trial (RCT) raised some of the early
fault lines developing between different interpretations of the study’s key data. The co-principal investigators (PIs)—Alik Farber, MD, Matthew Menard, MD, and Kenneth Rosenfield, MD—have hailed the study as the largest RCT comparing revascularization treatment strategies in patients with CLTI, and have outlined how it will provide important information regarding their management.
The trio stand at the vanguard of a study that set out to be a multidisciplinary endeavor. Yet, early disagreements exist even among the PIs themselves, a facet touched on before a packed standalone BEST-CLI session at the 2022 VEITHsymposium in New York City (Nov. 15–19) by Rosenfield himself. Results from BEST-CLI showed that surgical
See page 6
Vascular Specialist 9400 W. Higgins Road, Suite 315 Rosemont, IL 60018
CHANGE SERVICE REQUESTED
Presorted Standard U.S. Postage PAID Permit No. 384 Lebanon Jct. KY